HomeXENE • NASDAQ
add
Xenon Pharmaceuticals Inc
Previous close
$38.40
Day range
$38.37 - $39.43
Year range
$27.99 - $50.99
Market cap
2.92B USD
Avg Volume
309.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.40M | 67.49% |
Net income | -57.92M | -22.05% |
Net profit margin | — | — |
Earnings per share | -0.75 | -4.17% |
EBITDA | -68.44M | -24.40% |
Effective tax rate | 0.57% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 721.54M | 33.72% |
Total assets | 884.01M | 29.07% |
Total liabilities | 39.96M | 3.96% |
Total equity | 844.05M | — |
Shares outstanding | 75.76M | — |
Price to book | 3.44 | — |
Return on assets | -19.16% | — |
Return on capital | -19.72% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -57.92M | -22.05% |
Cash from operations | -32.68M | 1.63% |
Cash from investing | 110.72M | 296.81% |
Cash from financing | — | — |
Net change in cash | 77.84M | 1,669.31% |
Free cash flow | -33.97M | -15.67% |
About
Founded
1996
Headquarters
Website
Employees
255
